The present invention is directed toward the use of thyromimetic compoundsthat are thyroid receptor ligands, pharmaceutically acceptable salts thereof,and to prodrugs of these compounds for preventing, treating, or amelioratingfatty liver diseases such as steatosis, non-alcoholic fatty liver disease, andnon-alcoholic steatohepatitis.